| Literature DB >> 26084046 |
Hwa-Jeong Lee1, Sang Joon Lee2, Saji Uthaman3, Reju George Thomas4, Hoon Hyun5, Yong Yeon Jeong6, Chong-Su Cho7, In-Kyu Park8.
Abstract
Nanofibers are one-dimensional nanomaterial in fiber form with diameter less than 1 µm and an aspect ratio (length/diameter) larger than 100:1. Among the different types of nanoparticle-loaded nanofiber systems, nanofibers loaded with magnetic nanoparticles have gained much attention from biomedical scientists due to a synergistic effect obtained from the unique properties of both the nanofibers and magnetic nanoparticles. These magnetic nanoparticle-encapsulated or -embedded nanofiber systems can be used not only for imaging purposes but also for therapy. In this review, we focused on recent advances in nanofibers loaded with magnetic nanoparticles, their biomedical applications, and future trends in the application of these nanofibers.Entities:
Keywords: Cancer therapy; electrospinning; magnetic nanoparticles; nanofibers; tissue engineering
Mesh:
Substances:
Year: 2015 PMID: 26084046 PMCID: PMC4490516 DOI: 10.3390/ijms160613661
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Hybrid nanofibers and their applications.
| Hybrid Nanofiber | Precursor and Polymer/Dopant | Potential Application | Reference |
|---|---|---|---|
| CO3O4 | 1. Cobalt acetate; 2. PVA/ H2O | Biomarker | [ |
| Fe3O4 | 1. Iron (II) chloride; 2. Graft copolymer, poly(ethylene oxide) (PEO) or PVA | Drug carrier | [ |
| CeO2 | 1. Cerium nitrate; 2. PVA/H2O | Catalyst | [ |
| SiO2 | 1. Tetraethylorthosilicate; 2. HCl | Drug carrier | [ |
| Ca10(PO4)6(OH, F)2 | 1. Ca(NO3)2; 2. P(C2H5O)3 | Artificial bone | [ |
| Ta2O5 | 1. Tantalum isopropyl oxide; 2. PVAC/DMF (or acetic acid) | Implant | [ |
Figure 1Characterization of the super-paramagnetic nanofibrous scaffolds. (a) The scaffold pellet with diameter of ~5 mm; (b): Schematic representation of the scaffold pellet implanted into the lumbar transverse defect of a white rabbit lumbar vertebral segment L5; (c) SEM image of the scaffold showing randomly tangled nanofibers with diameters ranging from 300 to 1000 nm; and (d) The TEM image of a single fiber. Reprinted with permission from [32].
Figure 2Schematic representation of the ES setup showing arrangement for syringe, precursor solution, needle, liquid jet, collector, and a power supply.
Applications of nanofibers loaded with MNPs.
| Source of Nanofiber | Kind of MNPs | Technology | Application | Reference | |
|---|---|---|---|---|---|
| Chitosan / poly(vinyl alcohol) (PVA) | Fe3O4 | ES | Bone regeneration | MG63 human osteoblast–like cells | [ |
| Hydroxyapatite (HA) nanoparticles and poly(lactic acid) (PLA) | Super-paramagnetic Fe2O3 nanoparticles | ES | Bone tissue formation and remodeling in rabbit defects | White rabbit model of lumbar transverse defects | [ |
| Poly(ε-caprolactone) (PCL) | MNPs | ES | Bone regeneration | Osteoblastic cells and subcutaneously implanted in rats | [ |
| Hydroxyapatite (HA) | MNPs | Immersion of MNPs into HA scaffold | Bone repair | ROS 17/2.8 and MC3T3-E1 cells | [ |
| Magnetic poly( | Fe3O4 | ES | Enhanced effects on cell attachment and proliferation | MC3T3-E1 | [ |
| Poly( | Superpara-magnetic iron oxide nanoparticles (SPIONs) | ES | Cell proliferation and induction of the cell orientation | Osteoblast cells | [ |
| Chitosan | E-CHS-Fe3O4 | ES | Hyperthermia treatment of tumor cells | HFL1 and caco-2 cells | [ |
| Cross-linked chitosan | Fe3O4 | ES by iminodiacetic acid (IDA) | Reduction of tumor cell proliferation | Tumor cells | [ |
| Polystyrene (PS) and poly(styrene- | Magnetic NP-nanofibers (NF) | ES with surface-embedded T cell receptor ligand | Isolation and activation of primary CD3+ T lymphocytes | Lymph nodes harvested from C57BL/6 mice | [ |
| Porous hydroxyapatite composite | Up-conversion of luminescent and MNPs | ES | Indomethacin, T1 magnetic resonance imaging (MRI) contrast agents, and luminescent nanoparticles | MC 3T3-E1 cells | [ |
| Hydroxyapatite nanocrystals within PCL | Doped with gadolinium (Gd) | ES | Human mesenchymal stem cells | [ | |
| Amphiphilic peptide | Macrocyclic Gd (III) | β-sheet amino acid sequence | MRI | [ |
Figure 3MC3T3-E1 cell adhesion and penetration tests on the nanofiber scaffolds. (a) Initial cell adhesion level on the nanofiber scaffolds during culture for up to 16 h, presented as % initial seeding. Significantly higher levels of cell adhesion noticed on the PCL-MNP scaffolds vs. PCL (* p < 0.05); (b) Cell adhesion morphology taken from confocal microscopy of immunofluorescent stained cells at 2 h and 4 h of culture; nuclei in blue, F-actin in red and FAK in green; (c–e) Cell penetration assay through the nanofiber scaffolds; exemplar image showing that z-stacking of immunofluorescence-stained cells (F-actin in green and nuclei in blue) were unfolded on xz- and yz-planes to reveal 2D constructed images (c), which were then combined to complete construction of depth profile of cells on 2D plane view (d, compared images of PCL and 10MNP samples at a culture period of 3, 6 or 9 days), and the quantification of depth profile (e, shown average positions of cell penetration depth), showing significant improvement in cell penetration within the nanofibers incorporating MNPs. Reprinted with permission from [73].